KNSA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 54.57%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,380,104.31

Kiniksa Pharmaceuticals Insider Trading History Chart

Kiniksa Pharmaceuticals Share Price & Price History

^$22.61

▲ +0.45 (2.03%)

As of 03/14/2025 05:00 PM ET

Days: 30 | 90 | 365

Kiniksa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/12/2025	Mark Ragosa	CFO	Sell	36,372	$22.25	$809,277.00	22,958
3/12/2025	Michael R. Megna	CAO	Sell	9,051	$22.45	$203,194.95	26,528
2/10/2025	Eben Tessari	COO	Sell	14,000	$19.57	$273,980.00	81,975
1/13/2025	Eben Tessari	COO	Sell	14,000	$18.24	$255,360.00	88,975
12/5/2024	Mark Ragosa	CFO	Sell	1,123	$21.25	$23,863.75	22,958
12/3/2024	Mark Ragosa	CFO	Sell	8,969	$21.45	$192,385.05	22,958
10/15/2024	Eben Tessari	COO	Sell	17,000	$26.87	$456,790.00	109,975
9/23/2024	Eben Tessari	COO	Sell	17,500	$24.99	$437,325.00	116,975
9/3/2024	John F. Paolini	Insider	Sell	60,692	$26.12	$1,585,275.04	52,038
8/27/2024	Eben Tessari	COO	Sell	17,500	$26.91	$470,925.00	119,911
7/23/2024	John F. Paolini	Insider	Sell	22,000	$26.32	$579,040.00	47,803
7/23/2024	Mark Ragosa	CFO	Sell	24,248	$24.79	$601,107.92	19,253
7/23/2024	Sanj K. Patel	CEO	Sell	136,124	$25.65	$3,491,580.60	63,012
3/6/2024	Sanj K. Patel	CEO	Sell	5,582	$21.00	$117,222.00	65,012
3/4/2024	Sanj K. Patel	CEO	Sell	12,742	$21.49	$273,825.58	70,594
3/1/2024	Michael R. Megna	CAO	Sell	9,659	$21.45	$207,185.55	17,588
2/28/2024	Michael R. Megna	CAO	Sell	5,126	$21.79	$111,695.54	17,588
1/3/2024	Mark Ragosa	CFO	Sell	12,000	$20.00	$240,000.00	15,632
1/2/2024	Michael R. Megna	CAO	Sell	16,670	$19.17	$319,563.90	17,005
12/19/2023	Michael R. Megna	CAO	Sell	9,316	$19.13	$178,215.08	17,005
12/7/2023	John F. Paolini	Insider	Sell	28,600	$17.65	$504,790.00	44,892
9/5/2023	John F. Paolini	Insider	Sell	400	$17.53	$7,012.00	44,892
7/25/2023	John F. Paolini	Insider	Sell	29,000	$19.14	$555,060.00	41,910
11/29/2022	Barry D. Quart	Director	Sell	21,959	$16.15	$354,637.85

SEC Filings (Institutional Ownership Changes) for Kiniksa Pharmaceuticals (NASDAQ:KNSA)

53.95% of Kiniksa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Kiniksa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/27/2025	Jefferies Financial Group Inc.	112,400	$2.22M	0.0%	+39.5%	0.156%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	56,691	$1.12M	0.0%	+28.2%	0.079%
2/17/2025	Voloridge Investment Management LLC	140,878	$2.79M	0.0%	-25.8%	0.195%
2/17/2025	Woodline Partners LP	19,005	$0.38M	0.0%	-44.2%	0.026%
2/17/2025	Squarepoint Ops LLC	26,808	$0.53M	0.0%	N/A	0.037%
2/17/2025	State of Wyoming	14,806	$0.29M	0.0%	N/A	0.021%
2/17/2025	ProShare Advisors LLC	12,807	$0.25M	0.0%	+35.5%	0.018%
2/17/2025	Parkman Healthcare Partners LLC	765,453	$15.14M	2.0%	+1.4%	1.060%
2/17/2025	Nuveen Asset Management LLC	795,612	$15.74M	0.0%	+7.3%	1.102%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	99,632	$1.97M	0.2%	+32.5%	0.138%
2/17/2025	Millennium Management LLC	779,672	$15.42M	0.0%	+50.9%	1.080%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	21,841	$0.43M	0.0%	+6.7%	0.030%
2/17/2025	Lazard Asset Management LLC	3,098	$61K	0.0%	N/A	0.004%
2/17/2025	Lion Point Capital LP	45,900	$0.91M	4.8%	-25.2%	0.064%
2/17/2025	Jefferies Financial Group Inc.	112,400	$2.22M	0.0%	+39.5%	0.156%
2/17/2025	Hudson Bay Capital Management LP	225,000	$4.45M	0.0%	+150.0%	0.312%
2/17/2025	Granahan Investment Management LLC	463,110	$9.16M	0.4%	-8.7%	0.641%
2/17/2025	Fairmount Funds Management LLC	2,194,341	$43.40M	4.3%	-31.5%	3.039%
2/17/2025	Deutsche Bank AG	142,397	$2.82M	0.0%	+77.3%	0.197%
2/17/2025	D. E. Shaw & Co. Inc.	320,007	$6.33M	0.0%	-0.3%	0.443%
2/17/2025	Driehaus Capital Management LLC	613,550	$12.14M	0.1%	-16.1%	0.850%
2/17/2025	Braidwell LP	3,452,447	$68.29M	2.0%	+19.3%	4.782%
2/17/2025	Balyasny Asset Management L.P.	12,921	$0.26M	0.0%	N/A	0.018%
2/17/2025	Bellevue Group AG	8,100	$0.16M	0.0%	N/A	0.011%
2/17/2025	Bank of America Corp DE	215,772	$4.27M	0.0%	+2.2%	0.299%
2/17/2025	BNP Paribas Financial Markets	173,480	$3.43M	0.0%	-10.1%	0.240%
2/17/2025	Ameriprise Financial Inc.	51,076	$1.01M	0.0%	-70.9%	0.071%
2/17/2025	Algert Global LLC	135,814	$2.69M	0.1%	+49.0%	0.188%
2/17/2025	ArrowMark Colorado Holdings LLC	521,889	$10.32M	0.1%	-1.8%	0.723%
2/14/2025	Jane Street Group LLC	189,452	$3.75M	0.0%	-45.1%	0.262%
2/14/2025	PDT Partners LLC	64,917	$1.28M	0.1%	+74.3%	0.090%
2/14/2025	Schonfeld Strategic Advisors LLC	28,400	$0.56M	0.0%	-68.2%	0.039%
2/14/2025	Northern Trust Corp	283,599	$5.61M	0.0%	+11.1%	0.393%
2/14/2025	Nebula Research & Development LLC	29,521	$0.58M	0.1%	-24.3%	0.041%
2/14/2025	Oberweis Asset Management Inc.	237,200	$4.69M	0.2%	+18.0%	0.329%
2/14/2025	Voya Investment Management LLC	19,988	$0.40M	0.0%	+16.8%	0.028%
2/14/2025	Price T Rowe Associates Inc. MD	15,111	$0.30M	0.0%	+23.6%	0.021%
2/14/2025	Hsbc Holdings PLC	13,112	$0.26M	0.0%	-4.1%	0.018%
2/14/2025	Tower Research Capital LLC TRC	8,483	$0.17M	0.0%	+117.1%	0.012%
2/14/2025	MetLife Investment Management LLC	23,095	$0.46M	0.0%	+6.3%	0.032%
2/14/2025	Dimensional Fund Advisors LP	771,607	$15.26M	0.0%	+3.9%	1.069%
2/13/2025	Marshall Wace LLP	86,762	$1.72M	0.0%	-4.2%	0.120%
2/13/2025	Jump Financial LLC	14,601	$0.29M	0.0%	-68.0%	0.020%
2/13/2025	Barclays PLC	71,896	$1.42M	0.0%	+11.2%	0.100%
2/13/2025	Raymond James Financial Inc.	199,953	$3.96M	0.0%	N/A	0.277%
2/13/2025	Martingale Asset Management L P	49,360	$0.98M	0.0%	+1.9%	0.068%
2/13/2025	Legal & General Group Plc	41,267	$0.82M	0.0%	-18.0%	0.057%
2/13/2025	Invesco Ltd.	14,108	$0.28M	0.0%	-74.6%	0.020%
2/13/2025	ADAR1 Capital Management LLC	166,406	$3.29M	0.7%	-61.9%	0.230%
2/13/2025	Cerity Partners LLC	28,598	$0.57M	0.0%	-14.3%	0.040%
2/13/2025	Wells Fargo & Company MN	21,102	$0.42M	0.0%	+54.7%	0.029%
2/12/2025	ExodusPoint Capital Management LP	127,161	$2.52M	0.0%	+965.2%	0.176%
2/12/2025	Massachusetts Financial Services Co. MA	64,881	$1.28M	0.0%	-2.9%	0.090%
2/12/2025	Trexquant Investment LP	80,842	$1.60M	0.0%	-47.9%	0.112%
2/12/2025	Geode Capital Management LLC	492,630	$9.74M	0.0%	+2.0%	0.682%
2/12/2025	Wellington Management Group LLP	69,813	$1.38M	0.0%	+46.3%	0.097%
2/12/2025	Arrowstreet Capital Limited Partnership	22,453	$0.44M	0.0%	-86.1%	0.031%
2/12/2025	Pictet Asset Management Holding SA	1,133,931	$22.43M	0.0%	-6.1%	1.570%
2/12/2025	JPMorgan Chase & Co.	477,800	$9.45M	0.0%	+138.9%	0.662%
2/11/2025	Prudential Financial Inc.	91,920	$1.82M	0.0%	-22.6%	0.127%
2/11/2025	Corebridge Financial Inc.	15,430	$0.31M	0.0%	-5.0%	0.021%
2/11/2025	Advantage Alpha Capital Partners LP	8,890	$0.18M	0.0%	-56.4%	0.012%
2/11/2025	Vanguard Group Inc.	3,207,497	$63.44M	0.0%	-2.8%	4.443%
2/11/2025	KLP Kapitalforvaltning AS	8,000	$0.16M	0.0%	N/A	0.011%
2/11/2025	Knights of Columbus Asset Advisors LLC	60,966	$1.21M	0.1%	-16.2%	0.084%
2/11/2025	Sei Investments Co.	42,184	$0.83M	0.0%	-5.3%	0.058%
2/11/2025	Teacher Retirement System of Texas	10,862	$0.22M	0.0%	+7.1%	0.015%
2/10/2025	Globeflex Capital L P	88,596	$1.75M	0.1%	+217.1%	0.123%
2/10/2025	Swiss National Bank	71,900	$1.42M	0.0%	-8.5%	0.100%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	306,946	$6.07M	0.0%	-5.3%	0.425%
2/7/2025	Essex Investment Management Co. LLC	173,799	$3.44M	0.6%	-13.3%	0.241%
2/6/2025	Raymond James Financial Inc.	199,953	$3.96M	0.0%	N/A	0.277%
2/6/2025	Arizona State Retirement System	10,607	$0.21M	0.0%	-8.9%	0.015%
2/6/2025	Charles Schwab Investment Management Inc.	122,019	$2.41M	0.0%	+36.1%	0.169%
2/4/2025	Los Angeles Capital Management LLC	55,528	$1.10M	0.0%	-44.5%	0.077%
2/4/2025	Bank of New York Mellon Corp	122,051	$2.41M	0.0%	+33.1%	0.169%
2/4/2025	Y Intercept Hong Kong Ltd	13,050	$0.26M	0.0%	N/A	0.018%
1/31/2025	New York State Common Retirement Fund	15,248	$0.30M	0.0%	+12.4%	0.021%
1/31/2025	Rice Hall James & Associates LLC	642,752	$12.71M	0.7%	-1.1%	0.890%
1/31/2025	Peregrine Capital Management LLC	244,043	$4.83M	0.1%	+1.8%	0.338%
1/31/2025	Principal Financial Group Inc.	26,907	$0.53M	0.0%	-49.1%	0.037%
1/30/2025	Rhumbline Advisers	58,955	$1.17M	0.0%	-1.5%	0.082%
1/29/2025	Legato Capital Management LLC	51,379	$1.02M	0.1%	-23.4%	0.071%
1/29/2025	Allspring Global Investments Holdings LLC	49,309	$0.98M	0.0%	-14.4%	0.068%
1/24/2025	China Universal Asset Management Co. Ltd.	8,814	$0.17M	0.0%	+12.9%	0.012%
1/17/2025	SG Americas Securities LLC	17,970	$0.36M	0.0%	N/A	0.025%
1/15/2025	Hennion & Walsh Asset Management Inc.	199,525	$3.95M	0.2%	+1.9%	0.276%
1/6/2025	Nordea Investment Management AB	194,883	$3.82M	0.0%	+4.4%	0.270%
12/26/2024	JPMorgan Chase & Co.	199,973	$5M	0.0%	N/A	0.277%
12/19/2024	Principal Financial Group Inc.	52,851	$1.32M	0.0%	-21.1%	0.073%
11/27/2024	Franklin Resources Inc.	67,533	$1.80M	0.0%	+1.7%	0.094%
11/16/2024	Geode Capital Management LLC	482,976	$12.07M	0.0%	-43.1%	0.669%
11/15/2024	M&T Bank Corp	30,735	$0.77M	0.0%	-15.5%	0.043%
11/15/2024	XTX Topco Ltd	27,302	$0.68M	0.0%	+62.2%	0.038%
11/15/2024	Castleark Management LLC	167,200	$4.18M	0.2%	N/A	0.232%
11/15/2024	Jane Street Group LLC	345,092	$8.62M	0.0%	+1,064.4%	0.478%
11/15/2024	Wellington Management Group LLP	47,717	$1.19M	0.0%	N/A	0.066%
11/15/2024	State Street Corp	704,712	$17.61M	0.0%	-50.3%	0.976%
11/15/2024	Quarry LP	2,000	$50K	0.0%	N/A	0.003%
11/15/2024	Parkman Healthcare Partners LLC	755,244	$18.87M	2.4%	+16.7%	1.046%

Data available starting January 2016

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. The company was incorporated in 2015 and is based in Hamilton, Bermuda.

Today's Range

Now: $22.61

$22.02

$22.86

50 Day Range

MA: $19.95

$18.17

$22.50

52 Week Range

Now: $22.61

$16.56

$28.15

Volume

595,003 shs

Average Volume

406,826 shs

Market Capitalization

$1.64 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Who are the company insiders with the largest holdings of Kiniksa Pharmaceuticals?: Kiniksa Pharmaceuticals' top insider shareholders include:
Eben Tessari (COO)
Sanj K Patel (CEO)
John F Paolini (Insider)
Michael R Megna (CAO)
Mark Ragosa (CFO)
Learn More about top insider investors at Kiniksa Pharmaceuticals.
Who are the major institutional investors of Kiniksa Pharmaceuticals?: Kiniksa Pharmaceuticals' top institutional shareholders include:
Braidwell LP — 4.78%
Vanguard Group Inc. — 4.44%
Fairmount Funds Management LLC — 3.04%
Pictet Asset Management Holding SA — 1.57%
Nuveen Asset Management LLC — 1.10%
Millennium Management LLC — 1.08%
Learn More about top institutional investors of Kiniksa Pharmaceuticals stock.
Which major investors are selling Kiniksa Pharmaceuticals stock?: During the last quarter, KNSA stock was sold by these institutional investors:
Fairmount Funds Management LLC
ADAR1 Capital Management LLC
Jane Street Group LLC
Arrowstreet Capital Limited Partnership
Ameriprise Financial Inc.
Driehaus Capital Management LLC
Vanguard Group Inc.
Trexquant Investment LP
During the previous year, company insiders that have sold Kiniksa Pharmaceuticals company stock include:
Eben Tessari (COO)
Sanj K Patel (CEO)
John F Paolini (Insider)
Michael R Megna (CAO)
Mark Ragosa (CFO)
Learn More investors selling Kiniksa Pharmaceuticals stock.
Which major investors are buying Kiniksa Pharmaceuticals stock?: In the previous quarter, KNSA stock was bought by institutional investors including:
Braidwell LP
JPMorgan Chase & Co.
Millennium Management LLC
Raymond James Financial Inc.
Raymond James Financial Inc.
Hudson Bay Capital Management LP
ExodusPoint Capital Management LP
Deutsche Bank AG